Minimal Residual Disease MRD Analysis for TALL Test
Introduction
The Minimal Residual Disease (MRD) Analysis for TALL Test is an advanced diagnostic procedure that plays a pivotal role in the management of T-cell Acute Lymphoblastic Leukemia (TALL). This test is designed to detect minute quantities of leukemia cells that may remain in the body after treatment, providing critical information for ongoing patient management.
What the Test Measures
This test utilizes flow cytometry to identify and quantify specific cell surface and cytoplasmic markers associated with TALL. Key components measured include:
- CD3
- CD4
- CD5
- CD7
- CD8
- CD1a
- CD16
- CD56
- CD34
- TdT
- CD99
- CD117
- CD38
- CD10
- CD45
- CD2/CD13/CD15/CD33
Who Should Consider This Test?
Individuals diagnosed with T-cell Acute Lymphoblastic Leukemia, particularly those who have completed initial treatment, should consider undergoing this test. Symptoms that may prompt testing include:
- Persistent fatigue
- Unexplained fevers
- Frequent infections
- Unusual bruising or bleeding
Benefits of Taking the Test
Conducting the MRD Analysis offers several advantages:
- Early detection of residual disease, allowing for timely intervention.
- Improved treatment planning and monitoring of disease progression.
- Enhanced understanding of patient prognosis and potential outcomes.
Understanding Your Results
Results from the MRD Analysis will indicate the presence and quantity of residual leukemia cells. A lower number of residual cells typically correlates with a better prognosis. It is essential to discuss your results with your hematologist or oncologist to understand their implications fully.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Minimal Residual Disease MRD Analysis for TALL Test | 360,000 NGN | 500,000 NGN |
Booking the Test
To schedule your Minimal Residual Disease MRD Analysis for TALL Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and any inquiries you may have.
Sample Collection Instructions
For accurate results, it is mandatory to provide the Date & Time of sampling, Previous immunophenotype report, and Clinical history at the time of registration or before the sample is processed. The sample requirements include:
- 3 mL (1 mL min.) First pull Bone Marrow aspirate in 1 Green Top (Sodium Heparin) tube
- 4 mL (3 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube
Samples must be shipped immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
Turnaround Time
Samples are accepted daily by 9 am, with reports available within 3 working days.
